Zheng Lei, Ye Jianjun, Wang Qihao, Wu Qiyou, Chen Kai, Wei Qiang, Bao Yige
Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China; West China School of Medicine, Sichuan University, Chengdu, China; Department of Urology, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China; West China School of Medicine, Sichuan University, Chengdu, China.
Clin Genitourin Cancer. 2025 Aug;23(4):102352. doi: 10.1016/j.clgc.2025.102352. Epub 2025 Apr 15.
PURPOSE: The aim of this study was to determine the impact of the preoperative creatinine-cystatin C ratio (CCR) on the survival prognosis of patients following radical nephrectomy (RNU) for upper tract urothelial carcinoma (UTUC). METHODS: The retrospective analysis was conducted on UTUC patients who underwent radical nephrectomy (RNU) at West China Hospital between January 2009 and December 2019. The endpoint of the study was cancer-specific survival (CSS). Kaplan-Meier curves were used to estimate survival, and Cox proportional hazards modelling was used to assess risk. Nomograms were developed to predict CSS at 3 and 5 years of age, and the predictive power was assessed. RESULTS: A critical CCR of 59.61 µmol/mg was demonstrated to affect 504 patients with UTUC who had undergone RNU. A correlation was identified between a lower preoperative CCR and a considerably worse CSS. In patients with UTUC, CCR was identified as an independent risk factor for CSS, particularly in patients with locally advanced UTUC (pT ≥ 3) (HR: 1.84, 95% CI: 1.14, 2.97). Moreover, the CCR-based nomogram exhibited robust predictive capacity, with areas under the curve for the 3- and 5-year CSS reaching 0.823 and 0.793, respectively. CONCLUSION: Preoperative CCR is an independent predictor of CSS in UTUC patients receiving RNU treatment. As such, it should be viewed as a potentially useful customized tool in therapeutic decision-making.
目的:本研究旨在确定术前肌酐-胱抑素C比值(CCR)对上尿路尿路上皮癌(UTUC)患者根治性肾切除术(RNU)后生存预后的影响。 方法:对2009年1月至2019年12月在四川大学华西医院接受根治性肾切除术(RNU)的UTUC患者进行回顾性分析。研究的终点是癌症特异性生存(CSS)。采用Kaplan-Meier曲线估计生存率,采用Cox比例风险模型评估风险。绘制列线图以预测3岁和5岁时的CSS,并评估预测能力。 结果:504例接受RNU的UTUC患者的临界CCR为59.61µmol/mg。术前CCR较低与CSS明显较差之间存在相关性。在UTUC患者中,CCR被确定为CSS的独立危险因素,尤其是在局部晚期UTUC(pT≥3)患者中(HR:1.84,95%CI:1.14,2.97)。此外,基于CCR的列线图显示出强大的预测能力,3年和5年CSS的曲线下面积分别达到0.823和0.793。 结论:术前CCR是接受RNU治疗的UTUC患者CSS的独立预测因子。因此,它应被视为治疗决策中潜在有用的定制工具。
Clin Genitourin Cancer. 2025-8